Healthcare provider profile · identity verified

Renee G Watson, MD

Family Practice · SMITHFIELD, NC · NPI 1669420089

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	284	61
Losartan Potassium	Losartan Potassium	278	69
Amlodipine Besylate	Amlodipine Besylate	266	66
Pantoprazole Sodium	Pantoprazole Sodium	228	52
Omeprazole	Omeprazole	227	51
Levothyroxine Sodium	Levothyroxine Sodium	221	48
Tramadol Hcl	Tramadol Hcl	179	33
Sertraline Hcl	Sertraline Hcl	177	34
Pravastatin Sodium	Pravastatin Sodium	167	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	149	20
Metoprolol Succinate	Metoprolol Succinate	145	38
Lisinopril	Lisinopril	141	35
Metformin Hcl	Metformin Hcl	141	30
Rosuvastatin Calcium	Rosuvastatin Calcium	125	33
Gabapentin	Gabapentin	123	25
Alprazolam	Alprazolam	117	21
Jardiance	Empagliflozin	101	24
Escitalopram Oxalate	Escitalopram Oxalate	96	24
Furosemide	Furosemide	94	23
Trazodone Hcl	Trazodone Hcl	83	20
Famotidine	Famotidine	74	21
Ezetimibe	Ezetimibe	73	17
Simvastatin	Simvastatin	71	16
Meloxicam	Meloxicam	70	19
Potassium Chloride	Potassium Chloride	69	20
Atenolol	Atenolol	68	13
Mirtazapine	Mirtazapine	68	15
Metoprolol Tartrate	Metoprolol Tartrate	66	14
Donepezil Hcl	Donepezil Hcl	64	11
Hydrochlorothiazide	Hydrochlorothiazide	63	20
Allopurinol	Allopurinol	59	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	56	17
Clopidogrel	Clopidogrel Bisulfate	55	12
Eliquis	Apixaban	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Benazepril Hcl	Benazepril Hcl	47	suppressed
Lorazepam	Lorazepam	45	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	11
Spironolactone	Spironolactone	44	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	43	16
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Metformin Hcl Er	Metformin Hcl	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Montelukast Sodium	Montelukast Sodium	34	12
Prednisone	Prednisone	34	21
Ozempic	Semaglutide	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Temazepam	Temazepam	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Azithromycin	Azithromycin	26	18
Mounjaro	Tirzepatide	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Celecoxib	Celecoxib	22	12
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Nystatin	Nystatin	20	13
Amoxicillin	Amoxicillin	19	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Mupirocin	Mupirocin	17	13
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Levofloxacin	Levofloxacin	13	13
Propafenone Hcl	Propafenone Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error